Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GDRX GoodRx	$4.28 -0.6%	$4.55	$3.31 ▼ $8.16	$1.49B	1.23	1.98 million shs	323,687 shs
GS The Goldman Sachs Group	$730.68 0.0%	$720.29	$439.38 ▼ $753.33	$221.35B	1.41	2.49 million shs	261,359 shs
HIMS Hims & Hers Health	$44.87 +8.0%	$49.95	$13.47 ▼ $72.98	$10.15B	2.14	33.08 million shs	14.61 million shs
MS Morgan Stanley	$148.83 0.0%	$143.64	$94.09 ▼ $150.75	$237.74B	1.33	6.51 million shs	955,187 shs
ULTA Ulta Beauty	$535.12 +0.5%	$500.78	$309.01 ▼ $539.00	$23.98B	1.06	889,972 shs	330,508 shs
XLY Consumer Discretionary Select Sector SPDR Fund	$231.64 +0.7%	$224.05	$173.10 ▼ $240.28	$23.27B	1.18	4.52 million shs	2.21 million shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GDRX GoodRx	-1.15%	-0.69%	-5.08%	+7.23%	-45.57%
GS The Goldman Sachs Group	-2.08%	-2.50%	+2.89%	+21.73%	+43.05%
HIMS Hims & Hers Health	-1.74%	-8.52%	-33.47%	-22.60%	+182.59%
MS Morgan Stanley	-1.07%	-0.04%	+7.05%	+16.03%	+43.71%
ULTA Ulta Beauty	+8.08%	+1.23%	+4.88%	+14.36%	+50.92%
XLY Consumer Discretionary Select Sector SPDR Fund	-0.75%	-1.58%	+6.44%	+7.05%	+22.92%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GDRX GoodRx	4.2227 of 5 stars	3.2	4.0	0.0	0.0	3.3	2.5	3.1
GS The Goldman Sachs Group	4.6563 of 5 stars	2.2	4.0	4.2	3.0	1.6	2.5	2.5
HIMS Hims & Hers Health	3.3078 of 5 stars	2.0	2.0	0.0	0.0	3.4	3.3	3.1
MS Morgan Stanley	4.2968 of 5 stars	1.2	3.0	4.2	2.4	3.0	2.5	2.5
ULTA Ulta Beauty	3.5308 of 5 stars	2.2	3.0	0.0	1.8	3.5	1.7	1.3
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GDRX GoodRx	2.45	Hold	$5.80	35.67% Upside
GS The Goldman Sachs Group	2.33	Hold	$660.00	-9.67% Downside
HIMS Hims & Hers Health	1.92	Reduce	$38.92	-13.26% Downside
MS Morgan Stanley	2.47	Hold	$138.25	-7.11% Downside
ULTA Ulta Beauty	2.44	Hold	$536.75	0.30% Upside
XLY Consumer Discretionary Select Sector SPDR Fund	2.67	Moderate Buy	$231.89	0.11% Upside

Current Analyst Ratings Breakdown

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/2/2025	ULTA Ulta Beauty	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$589.00 ➝ $617.00
9/2/2025	ULTA Ulta Beauty	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform	$590.00 ➝ $610.00
8/29/2025	ULTA Ulta Beauty	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
8/29/2025	ULTA Ulta Beauty	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$640.00 ➝ $680.00
8/29/2025	ULTA Ulta Beauty	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$650.00
8/29/2025	ULTA Ulta Beauty	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underweight ➝ Underweight	$400.00 ➝ $425.00
8/29/2025	ULTA Ulta Beauty	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$585.00 ➝ $625.00
8/29/2025	ULTA Ulta Beauty	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$530.00 ➝ $584.00
8/29/2025	ULTA Ulta Beauty	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$550.00 ➝ $600.00
8/29/2025	ULTA Ulta Beauty	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$580.00 ➝ $605.00
8/19/2025	HIMS Hims & Hers Health	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold

(Data available from 9/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GDRX GoodRx	$792.32M	1.87	$0.31 per share	13.67	$1.85 per share	2.31
GS The Goldman Sachs Group	$126.85B	1.74	$52.64 per share	13.88	$359.88 per share	2.03
HIMS Hims & Hers Health	$1.48B	6.87	$0.37 per share	120.26	$2.49 per share	18.02
MS Morgan Stanley	$107.29B	2.21	$11.39 per share	13.07	$62.34 per share	2.39
ULTA Ulta Beauty	$11.30B	2.12	$34.39 per share	15.56	$58.07 per share	9.22
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GDRX GoodRx	$16.39M	$0.10	42.75	23.75	1.90	4.33%	8.86%	4.50%	11/6/2025 (Estimated)
GS The Goldman Sachs Group	$14.28B	$45.38	16.11	14.03	1.58	12.37%	14.32%	0.89%	10/14/2025 (Estimated)
HIMS Hims & Hers Health	$126.04M	$0.80	56.16	86.28	2.86	9.63%	26.26%	13.06%	11/3/2025 (Estimated)
MS Morgan Stanley	$13.39B	$8.83	16.87	15.78	1.88	13.06%	15.20%	1.15%	10/15/2025 (Estimated)
ULTA Ulta Beauty	$1.20B	$26.08	20.51	22.62	2.88	10.31%	48.78%	19.55%	N/A
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	27.10	∞	N/A	N/A	N/A	N/A	N/A

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/28/2025	Q2 2026	ULTA Ulta Beauty	$5.03	$5.78	+$0.75	$5.78	$2.66 billion	$2.79 billion
8/6/2025	Q2 2025	GDRX GoodRx	$0.10	$0.09	-$0.01	$0.04	$205.72 million	$203.07 million
8/4/2025	Q2 2025	HIMS Hims & Hers Health	$0.18	$0.17	-$0.01	$0.17	$550.06 million	$544.83 million
7/16/2025	Q2 2025	GS The Goldman Sachs Group	$9.82	$10.91	+$1.09	$10.91	$13.53 billion	$14.58 billion
7/16/2025	Q2 2025	MS Morgan Stanley	$1.98	$2.13	+$0.15	$2.13	$16.15 billion	$16.79 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GDRX GoodRx	N/A	N/A	N/A	N/A	N/A
GS The Goldman Sachs Group	$16.00	2.19%	N/A	35.26%	13 Years
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
MS Morgan Stanley	$4.00	2.69%	N/A	45.30%	12 Years
ULTA Ulta Beauty	N/A	N/A	N/A	N/A	N/A
XLY Consumer Discretionary Select Sector SPDR Fund	$1.82	0.79%	N/A	N/A	N/A

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/14/2025	GS The Goldman Sachs Group	quarterly	$4.00	2.15%	8/29/2025	8/29/2025	9/29/2025
7/16/2025	MS Morgan Stanley	quarterly	$1.00	2.6%	7/31/2025	7/31/2025	8/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GDRX GoodRx	0.75	4.21	4.21
GS The Goldman Sachs Group	2.57	0.67	0.67
HIMS Hims & Hers Health	1.72	4.98	4.46
MS Morgan Stanley	3.30	0.78	0.78
ULTA Ulta Beauty	N/A	1.39	0.46
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GDRX GoodRx	63.77%
GS The Goldman Sachs Group	71.21%
HIMS Hims & Hers Health	63.52%
MS Morgan Stanley	84.19%
ULTA Ulta Beauty	90.39%
XLY Consumer Discretionary Select Sector SPDR Fund	69.93%

Insider Ownership

Company	Insider Ownership
GDRX GoodRx	4.17%
GS The Goldman Sachs Group	0.55%
HIMS Hims & Hers Health	17.71%
MS Morgan Stanley	0.19%
ULTA Ulta Beauty	0.39%
XLY Consumer Discretionary Select Sector SPDR Fund	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GDRX GoodRx	950	347.45 million	332.96 million	Optionable
GS The Goldman Sachs Group	46,500	302.72 million	301.06 million	Optionable
HIMS Hims & Hers Health	1,637	226.02 million	185.99 million	Optionable
MS Morgan Stanley	80,000	1.60 billion	1.59 billion	Optionable
ULTA Ulta Beauty	58,000	44.84 million	44.66 million	Optionable
XLY Consumer Discretionary Select Sector SPDR Fund	147,000	100.40 million	N/A	Not Optionable

XLY, HIMS, GS, MS, GDRX, and ULTA Headlines

Recent News About These Companies

What to Expect From the Q3 Reporting Season (XLY)

...

4 hours ago | marketbeat.com

Royal Caribbean, Deckers, MGM Shine As Consumer Stocks Extend Weekly Gains After Powell's Rate-Cut Tease

August 25, 2025 | msn.com

XLY: Don't Expect Consumer Spending To Notably Recover Until 2026

August 21, 2025 | seekingalpha.com

Consumer Strength Signal Flashing Short-Term Caution Sign

August 20, 2025 | schaeffersresearch.com

Are Cyclical ETFs Worth the Boom and Bust?

August 18, 2025 | finance.yahoo.com

Lululemon, Wendy’s, Peloton Get Some Institutional Love As Hedge Funds Shuffle Consumer Stocks Deck

August 15, 2025 | msn.com

5 ETFs to Benefit if Fed Cuts Rate in September

August 11, 2025 | zacks.com

What Tariffs Mean for Your Sector Exposure

August 8, 2025 | msn.com

Should You Invest in the Consumer Discretionary Select Sector SPDR ETF (XLY)?

August 6, 2025 | zacks.com

Trump Tariff Blows Didn’t Stop These 3 Stocks From Defying Last Week’s Consumer Slump

August 4, 2025 | msn.com

Looking for Exposure to Amazon Stock (AMZN) Post Q2 Dip? Try These Two ETFs

August 2, 2025 | msn.com

Strong Start to Q2 Earnings Season: 4 Sector ETFs to Play

July 30, 2025 | zacks.com

4 Sector ETFs to Play on Improving Earnings Trends

July 28, 2025 | zacks.com

Earnings Scoreboard: 12 of 17 consumer cyclical stocks beat estimates last week

July 27, 2025 | msn.com

Consumer Durables: Overview, What They Are, Example

July 25, 2025 | fool.com

ETFs to Consider as Consumer Sentiment Improves in July

July 21, 2025 | zacks.com

Weekly Economic Snapshot: Consumer Spending Rebounds Despite Rising Inflation

July 21, 2025 | etftrends.comE

Consumer Stocks Post Weekly Gains As Retail Sales Rebound, Inflation Picks Up: Here Are The Top 3 Winners

July 21, 2025 | msn.com

The Market Rally Is Gaining Momentum—Don’t Get Left Behind (XLY)

...

July 17, 2025 | marketbeat.com

5 Sector ETFs Set to Power Q2 Earnings Growth

July 10, 2025 | zacks.com

S&P 500 consumer discretionary sector jumps 8.9% in Q2, Royal Caribbean Cruises, Carnival, Lululemon Athletica among top movers

July 3, 2025 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

XLY, HIMS, GS, MS, GDRX, and ULTA Company Descriptions

GoodRx NASDAQ:GDRX

$4.28 -0.03 (-0.58%)

As of 11:26 AM Eastern

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

The Goldman Sachs Group NYSE:GS

$730.68 -0.17 (-0.02%)

As of 11:26 AM Eastern

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.

Hims & Hers Health NYSE:HIMS

$44.87 +3.34 (+8.04%)

As of 11:26 AM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Morgan Stanley NYSE:MS

$148.83 -0.02 (-0.02%)

As of 11:26 AM Eastern

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels. The company was founded in 1924 and is headquartered in New York, New York.

Ulta Beauty NASDAQ:ULTA

$535.12 +2.60 (+0.49%)

As of 11:26 AM Eastern

Ulta Beauty, Inc. operates as a specialty beauty retailer in the United States. The company offers branded and private label beauty products, including cosmetics, fragrance, haircare, skincare, bath and body products, professional hair products, and salon styling tools through its Ulta Beauty stores, shop-in-shops, Ulta.com website, and its mobile applications. It also offers beauty services, including hair, makeup, brow, and skin services at its stores. The company was formerly known as ULTA Salon, Cosmetics & Fragrance, Inc. and changed its name to Ulta Beauty, Inc. in January 2017. Ulta Beauty, Inc. was incorporated in 1990 and is based in Bolingbrook, Illinois.

Consumer Discretionary Select Sector SPDR Fund NYSEARCA:XLY

$231.64 +1.63 (+0.71%)

As of 11:26 AM Eastern

Consumer Discretionary Select Sector SPDR Fund seeks to provide investment results that correspond generally to the price and yield performance of the Consumer Discretionary Select Sector Index (the Index). The Index includes companies from the following industries, media; retail (specialty, multiline, Internet and catalog); hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure equipment and products; and diversified consumer services. The Fund's investment advisor is SSgA Funds Management, Inc.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Earnings

Compare Dividends

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

XLY, HIMS, GS, MS, GDRX, and ULTA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

XLY, HIMS, GS, MS, GDRX, and ULTA Company Descriptions

GoodRx NASDAQ:GDRX

The Goldman Sachs Group NYSE:GS

Hims & Hers Health NYSE:HIMS

Morgan Stanley NYSE:MS

Ulta Beauty NASDAQ:ULTA

Consumer Discretionary Select Sector SPDR Fund NYSEARCA:XLY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools